↓ Skip to main content

Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

Overview of attention for article published in Critical Care, May 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
5 X users

Citations

dimensions_citation
175 Dimensions

Readers on

mendeley
163 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?
Published in
Critical Care, May 2013
DOI 10.1186/cc12705
Pubmed ID
Authors

Mieke Carlier, Sofie Carrette, Jason A Roberts, Veronique Stove, Alain Verstraete, Eric Hoste, Pieter Depuydt, Johan Decruyenaere, Jeffrey Lipman, Steven C Wallis, Jan J De Waele

Abstract

Correct antibiotic dosing remains a challenge for the clinician. The aim of this study was to assess the influence of augmented renal clearance on pharmacokinetic/pharmacodynamic target attainment in critically ill patients receiving meropenem or piperacillin/tazobactam, administered as an extended infusion.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Japan 1 <1%
Canada 1 <1%
Unknown 159 98%

Demographic breakdown

Readers by professional status Count As %
Other 24 15%
Researcher 24 15%
Student > Ph. D. Student 18 11%
Student > Master 16 10%
Student > Doctoral Student 11 7%
Other 36 22%
Unknown 34 21%
Readers by discipline Count As %
Medicine and Dentistry 75 46%
Pharmacology, Toxicology and Pharmaceutical Science 34 21%
Agricultural and Biological Sciences 5 3%
Biochemistry, Genetics and Molecular Biology 2 1%
Immunology and Microbiology 2 1%
Other 6 4%
Unknown 39 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2018.
All research outputs
#2,866,372
of 25,394,764 outputs
Outputs from Critical Care
#2,455
of 6,558 outputs
Outputs of similar age
#23,720
of 204,438 outputs
Outputs of similar age from Critical Care
#16
of 152 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,558 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,438 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 152 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.